Merck to invest $70m for R&D facility expansion in Massachusetts
Category: #health  | By Mateen Dalal  | Date: 2019-02-07 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Merck to invest $70m for R&D facility expansion in Massachusetts

The building construction is scheduled to be completed in 2021 and is designed to offer office space, wet labs and a cafeteria.

Merck, one of the leaders in the pharmaceutical industry recently announced that it will be investing $70 million for the expansion of its R&D facility in Massachusetts. The new building will reportedly cover an area of 145,000 square feet and offer collaborative working and laboratory space for the 400 new and current R&D employees. The research and development activities will be focused on immunology, immuno-oncology and oncology.

Luciano Rossetti, Head of Global R&D at Biopharma business, Merck, has been quoted to say that the passionate and talented R&D teams in Billerica, Massachusetts are intensely engaged in advancing various pipeline compounds. He added that Merck continues to strengthen its innovation footprint in Darmstadt, Germany where its global R&D headquarters are located besides expanding in the U.S., aiming to deliver transformational value to patients across the globe.

Reliable sources report that with the latest development, Merck’s investment in infrastructure will cross $150 million in biopharmaceutical R&D advancement in Massachusetts. Such advancements have led to the creation of more than 150 new jobs ever since the Billerica R&D Hub was founded in 2011. The town of Billerica worked collaboratively with company officials and played a key role in the fruition of the latest building expansion project by underscoring the advantages of state-of-the-art R&D facility expansion.

Travis McCready, CEO and President of the Massachusetts Life Sciences Center reportedly said that by continual investment in the state of Massachusetts Merck has become a testament to the state's global leadership in life sciences. He added that in collaboration with the town of Billerica, the company has not only succeeded in retaining top talent in the area but also significantly contributed towards improving the lives of people with serious medical needs.

The building construction is scheduled to be completed in 2021 and is designed to offer office space, wet labs and a cafeteria. The building will have LEED® and WELL certifications and conform to environmental and employee wellness standards.

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal     twitter

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More..

More News By Mateen Dalal

ChatGPT’s creator OpenAI proposes regulation of AI by humans

ChatGPT’s creator OpenAI proposes regulation of AI by humans

By Mateen Dalal

OpenAI, the creator of ChatGPT, has reportedly put forward a proposal for the establishment of an international organization to regulate artificial intelligence (AI). Led by CEO Sam Altman, the company believes that AI systems developed within the ne...

Medtronic pledges USD 350 Mn to expand R&D operations in India

Medtronic pledges USD 350 Mn to expand R&D operations in India

By Mateen Dalal

Medtronic, a leading healthcare technology company, has announced plans to expand its R&D center in Hyderabad, India, with a whopping investment of USD 350 million. The existing facility is already the largest center for the company outside the U...

DuPont to buy Spectrum Plastics, anticipates high ROIC by fifth year

DuPont to buy Spectrum Plastics, anticipates high ROIC by fifth year

By Mateen Dalal

American chemical company DuPont de Nemours Inc. reportedly signed a definitive agreement to buy out Spectrum Plastics Group from AEA Investors, a U.S. based private equity firm. The acquisition will reinforce DuPont’s position in booming non-c...